First Front-Line Immunotherapy OK'd for Advanced Gastric Cancer

(MedPage Today) -- The FDA approved nivolumab (Opdivo) plus chemotherapy as the first immunotherapy-containing regimen for previously untreated advanced/metastatic gastric or esophageal cancer.The approval encompasses gastric, gastroesophageal...